Thu 20 Aug 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
| Study Title | Study Sponsor | Status | Study Drug | Trial Phase | Study Protocol Number | Site |
|---|---|---|---|---|---|---|
| Effects of Add on Pegylated Interferon therapy in patients of Chronic hepatitis B in maintained response with ongoing nucleos(t)ide analogues ; A multicenter, prospective, randomized open label trial. | KAIMRC | Ongoing | PEGINTERFERON ALFA-2A, RO258310 RIBAVIRIN, R0209963 | 3 | RC14-055-R | NGHA-R |
| Effect of subcutaneous semaglutide 2.4 mg once-weekly compared to placebo in subjects with obesity and knee osteoarthritis | Novo Nordisk | Ongoing | semaglutide | 3 | NN9536-4578 | King Fahad Medical City (Riyadh) |
| Effect of Preoperative Administration of Ibuprofen in Children Undergoing Extraction for Reducing Postoperative Pain: A Double-blind Randomized Controlled Clinical Trial | Princess Nourah University | Completed | ibuprofen | 3 | 18-0253 | PNU-CD |
| Effect of Gum Arabic supplementation on butyrate, uremic retention molecules and inflammation in chronic kidney disease patients | King Fahad Specialist Hospital - Dammam / KACST | Completed | Gum Arabic / E-114 | 2 | 2 | KFSH |
| Early administration of Tocilizumab in Immunocompromised and potential high-risk patients for developing COVID-19 | King Faisal Specialist Hospital & Research Centre | Completed | TOCILIZUMAB | 2 | 2201070 | KFSH&RC-R |
| Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG) | KKUH | Ongoing | Heparin - Enoxaparin - Tinzaparin - Fondaparinux | 3 | 1.2 | King Khalid University Hospital (Riyadh) |
| "Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic ( RAPID COVID COAG) " | KAIMRC | Completed | TINZAPARIN SODIUM | 3 | RC20/403 | King Abdulaziz Medical City NG (Riyadh) |
| Circulating Endotoxin as a Contributing Inflammatory Mediator in Osteoporosis Risk and its Association with Vitamin D Deficiency | National Plan for Science and Technology | Ongoing | Vitamin D3 VS. Alendronate | 3 | 11-MED-2113-02 or (G1109-665) | KFMC |
| Cholecalciferol supplementation in critically ill patients with severe vitamin D deficiency in intensive care unit – a randomized controlled trial | King Abdullah Medical City, Makkah | Ongoing | VITAMIN D3 (CHOLECALCIFEROL) | 3 | IRB#16-252, V2 | KAMC |
| Bi-weekly Cetuximab and XELIRI(Capecitabine and Irinotecan) as first line therapy in K/N-RAS wild type advanced colorectal cancer: Phase I-II CETUXIRI study | King Faisal Specialist Hospital and Research Centre | Completed | Cetuximab | 1/2 | 1 , 29/07/2015 | KFSH&RC-R |
Last update date: 08/05/2025 at 03:17 PM Saudi Arabia time
No feedback has been submitted for this page yet.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.